About Quarterly Earnings Report Disclosures
| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥3.42B | ¥3.64B | -5.9% |
| Cost of Sales | ¥2.50B | ¥2.85B | -12.2% |
| Gross Profit | ¥921M | ¥787M | +17.1% |
| SG&A Expenses | ¥673M | ¥652M | +3.2% |
| Operating Income | ¥248M | ¥134M | +85.1% |
| Non-operating Income | ¥13M | ¥28M | -54.1% |
| Non-operating Expenses | ¥46M | ¥43M | +8.6% |
| Ordinary Income | ¥214M | ¥119M | +79.8% |
| Profit Before Tax | ¥69M | ¥98M | -29.2% |
| Income Tax Expense | ¥32M | ¥39M | -20.1% |
| Net Income | ¥38M | ¥58M | -35.4% |
| Net Income Attributable to Owners | ¥37M | ¥58M | -36.2% |
| Total Comprehensive Income | ¥38M | ¥18M | +111.1% |
| Depreciation & Amortization | ¥143M | ¥144M | -0.6% |
| Interest Expense | ¥33M | ¥27M | +22.4% |
| Basic EPS | ¥29.61 | ¥45.82 | -35.4% |
| Dividend Per Share | ¥78.00 | ¥78.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥5.74B | ¥6.46B | ¥-713M |
| Cash and Deposits | ¥1.58B | ¥2.34B | ¥-755M |
| Accounts Receivable | ¥1.41B | ¥1.50B | ¥-83M |
| Inventories | ¥667M | ¥642M | +¥26M |
| Non-current Assets | ¥4.61B | ¥4.59B | +¥15M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥40M | ¥201M | ¥-161M |
| Financing Cash Flow | ¥-494M | ¥-90M | ¥-403M |
| Item | Value |
|---|---|
| Net Profit Margin | 1.1% |
| Gross Profit Margin | 26.9% |
| Current Ratio | 130.8% |
| Quick Ratio | 115.6% |
| Debt-to-Equity Ratio | 1.58x |
| Interest Coverage Ratio | 7.49x |
| EBITDA Margin | 11.4% |
| Effective Tax Rate | 45.7% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -5.9% |
| Operating Income YoY Change | +84.0% |
| Ordinary Income YoY Change | +79.2% |
| Net Income Attributable to Owners YoY Change | -35.4% |
| Total Comprehensive Income YoY Change | +102.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 1.29M shares |
| Treasury Stock | 19K shares |
| Average Shares Outstanding | 1.27M shares |
| Book Value Per Share | ¥3,161.36 |
| EBITDA | ¥391M |
| Item | Amount |
|---|---|
| Year-End Dividend | ¥78.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| MedicalEquipment | ¥1.09B | ¥47M |
| PrecisionEquipment | ¥2.21B | ¥540M |
| SP | ¥34M | ¥-36M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥7.46B |
| Operating Income Forecast | ¥572M |
| Ordinary Income Forecast | ¥488M |
| Net Income Attributable to Owners Forecast | ¥283M |
| Basic EPS Forecast | ¥223.26 |
| Dividend Per Share Forecast | ¥82.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
| Property, Plant & Equipment | ¥4.20B | ¥4.22B | ¥-20M |
| Intangible Assets | ¥63M | ¥38M | +¥26M |
| Total Assets | ¥10.36B | ¥11.06B | ¥-700M |
| Current Liabilities | ¥4.39B | ¥4.81B | ¥-419M |
| Accounts Payable | ¥303M | ¥240M | +¥63M |
| Short-term Loans | ¥2.68B | ¥2.89B | ¥-205M |
| Non-current Liabilities | ¥1.96B | ¥2.18B | ¥-219M |
| Long-term Loans | ¥1.30B | ¥1.47B | ¥-163M |
| Total Liabilities | ¥6.35B | ¥6.99B | ¥-639M |
| Total Equity | ¥4.01B | ¥4.07B | ¥-61M |
| Capital Stock | ¥643M | ¥643M | ¥0 |
| Capital Surplus | ¥248M | ¥248M | ¥0 |
| Retained Earnings | ¥2.78B | ¥2.77B | +¥10M |
| Treasury Stock | ¥-42M | ¥-41M | ¥-297,000 |
| Owners' Equity | ¥4.01B | ¥4.07B | ¥-61M |
| Working Capital | ¥1.35B | - | - |